Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Enhancing Support for Women With Type 2 Diabetes: Follow-Up
This study is ongoing, but not recruiting participants.
Sponsors and Collaborators: Oregon Research Institute
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: Oregon Research Institute
ClinicalTrials.gov Identifier: NCT00680849
  Purpose

This study is a 5-year continuation of "The Mediterranean Lifestyle Program." The purpose of this follow-up study is to determine the long-term effects from prior participation in an intervention promoting healthful eating, exercise, quitting smoking, stress management, and social support. Participants are post-menopausal women with type 2 diabetes.


Condition
Type 2 Diabetes Mellitus

MedlinePlus related topics: Diabetes
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Enhancing Support for Women With Type 2 Diabetes: Follow-Up

Further study details as provided by Oregon Research Institute:

Primary Outcome Measures:
  • Food Frequency Questionnaire for Fruits, Vegetables and percent calories from fat (FFQ) by Kristal and colleagues [ Time Frame: annually, 36 months - 84 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Lipids, weight loss [ Time Frame: annually, 36 months - 84 months ] [ Designated as safety issue: No ]

Biospecimen Retention:   None Retained

Biospecimen Description:

Enrollment: 227
Study Start Date: December 2003
Estimated Study Completion Date: December 2008
Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Treatment condition from first study. This is a follow-up study.
2
Control condition from first study.

Detailed Description:

Coronary heart disease (CHD) is the leading cause of death and functional limitations among women in the U.S. Postmenopausal women with diabetes are at especially high risk of CHD, but CHD research with this population is very limited. This project addresses the poorly understood "natural history" of long-term maintenance of change in multiple behaviors (i.e., dietary, physical activity, social support, smoking cessation, and stress management) related to CHD risk, as well as the effects of theoretically important mediating variables on relapse and maintenance. The study is a continuation of a research project that has already demonstrated significant and consistent positive effects of a lifestyle change intervention on reduction of behavioral CHD risk factors. This research relies on a framework that synthesizes social-cognitive, social-ecologic, and goal-systems theories.

  Eligibility

Ages Eligible for Study:   40 Years to 75 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Participants in prior study: Enhancing Support for Women With Type 2 Diabetes, "The Mediterranean Lifestyle Program."

Criteria

Inclusion Criteria: All participants in the original study are eligible. The inclusion criteria for the original study were:

  • diagnosis of type 2 diabetes for at least 6 months
  • being post-menopausal
  • living independently (e.g., not in an institution or nursing home)
  • having a telephone
  • ability to read English
  • not being developmentally disabled, and
  • living within 30 miles of the Eugene-Springfield metropolitan area.

Exclusion Criteria: Exclusion criteria for the original study included:

  • being older than 75 years of age
  • having life-threatening illnesses, or
  • planning to move from the local area within the time span of the study.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00680849

Locations
United States, Oregon
Oregon Research Institute
Eugene, Oregon, United States, 97403
Sponsors and Collaborators
Oregon Research Institute
Investigators
Principal Investigator: Deborah J. Toobert, Ph.D. Oregon Research Institute
  More Information

Publications:
Responsible Party: Oregon Research Institute ( Deborah Toobert, Ph.D. )
Study ID Numbers: HL077120
Study First Received: May 16, 2008
Last Updated: May 16, 2008
ClinicalTrials.gov Identifier: NCT00680849  
Health Authority: United States: Institutional Review Board;   United States: Federal Government

Keywords provided by Oregon Research Institute:
Type 2 Diabetes Mellitus
Coronary Disease

Study placed in the following topic categories:
Coronary Disease
Metabolic Diseases
Diabetes Mellitus, Type 2
Diabetes Mellitus
Endocrine System Diseases
Endocrinopathy
Metabolic disorder
Glucose Metabolism Disorders
Coronary Artery Disease

ClinicalTrials.gov processed this record on January 14, 2009